Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nagy Rizkalla"'
Autor:
Livingstone Fultang, Silvia Panetti, Margaret Ng, Paul Collins, Suzanne Graef, Nagy Rizkalla, Sarah Booth, Richard Lenton, Boris Noyvert, Claire Shannon-Lowe, Gary Middleton, Francis Mussai, Carmela De Santo
Publikováno v:
EBioMedicine, Vol 47, Iss , Pp 235-246 (2019)
Background: Targeting of MDSCs is a major clinical challenge in the era of immunotherapy. Antibodies which deplete MDSCs in murine models can reactivate T cell responses. In humans such approaches have not developed due to difficulties in identifying
Externí odkaz:
https://doaj.org/article/4484df2a46f841cf91fd257440db08ae
Autor:
Tin Sein, Karim Anis, Nagy Rizkalla, Mashuk Khan, Lucie Jones, Simon Harries, Ruvinder Athwal
Publikováno v:
European Journal of Surgical Oncology. 49:e241-e242
Publikováno v:
British Journal of Surgery. 109
Background In 2020 we assessed changes in delivery of emergency surgeries due to the pandemic in a local district general hospital. Significant delays in emergency theatre utilisation were partly abrogated with the early introduction of a second emer
Autor:
Nagy Rizkalla, Tin Sein, Karim Anis, Hassan Al Omishy, Katherina McEvoy, Ruvinder Athwal, Mohamed Sait, Mashuk Khan, Hamed Khan, Simon Harries, Stuart Robertson, Lucie Jones
Publikováno v:
European Journal of Surgical Oncology. 49:e234
Autor:
Nagy Rizkalla, Anjeevan Clair, Tunde Salawa, Roshni Prema, Hassan Al Omishy, Hamed Khan, Mohamed Sait, Katherina McEvoy, Stuart Robertson
Publikováno v:
European Journal of Surgical Oncology. 49:e259
Autor:
Nagy Rizkalla, Kimberley Dubois, Stephanie Harding, Sarika Grover, Mina Manasseh, Al Omishy Hassan, Mohamed Sait, Hamed Khan, Katherina McEvoy, Stuart Robertson
Publikováno v:
European Journal of Surgical Oncology. 49:e247
Autor:
Gary Middleton, Francis Mussai, Carmela De Santo, Luciana Gneo, Rahul K. Hejmadi, Nagy Rizkalla
Publikováno v:
Cancer immunology, immunotherapy : CII. 71(7)
BackgroundMonocytic myeloid-derived suppressor cells (M-MDSCs) are significantly expanded in the blood of colorectal cancer (CRC) patients. However, their presence and underlying mechanisms in the tumour microenvironment of CRC have not been examined
MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers
Autor:
Gary Middleton, Nagy Rizkalla, Richard Lenton, Margaret H.L. Ng, Carmela De Santo, Livingstone Fultang, Boris Noyvert, Suzanne Graef, Claire Shannon-Lowe, Sarah Booth, Francis Mussai, Paul Collins, Silvia Panetti
Publikováno v:
EBIOMEDICINE
EBioMedicine
EBioMedicine
Background: Targeting of MDSCs is a major clinical challenge in the era of immunotherapy. Antibodies which deplete MDSCs in murine models can reactivate T cell responses. In humans such approaches have not developed due to difficulties in identifying
Publikováno v:
Journal of Pain & Relief.
Autor:
Mehboob Mirza, Martin Sintler, Elizabeth Li, Simerjit Rai, Hamish Brown, Luna Vishwanath, Fiona Hoar, Nagy Rizkalla
Publikováno v:
European Journal of Surgical Oncology (EJSO). 41:S39-S40